Evidence map›Paper›PMID 31963708›Full record

Trial reportNutrients2020

Docosahexaenoic Acid (DHA) Bioavailability in Humans after Oral Intake of DHA-Containing Triacylglycerol or the Structured Phospholipid AceDoPC

Mayssa Hachem, Houda Nacir, Madeleine Picq, Mounir Belkouch, Nathalie Bernoud-Hubac, Anthony Windust, Laure Meiller, Valerie Sauvinet, Nathalie Feugier, Stephanie Lambert-Porcheron and 2 more

Registry-linked trialOpen access · goldAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02168738 (Bioavailability of DHA-TG), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02168738 nacompletednot on this map

Bioavailability of DHA-TG (Docosahexaenoic Triglyceride), DHA-PC (Docosahexaenoic Phosphatidylcholine) and AcedoPC (1-acetyl-2-docosahexaenoic-glycerophosphocholine) in Human

TypeinterventionalSponsorHospices Civils de LyonRan2014 to 2015Enrolled4ConditionsHealthy SubjectArms13-C labeled AceDoPC-DHA, 13-C labeled TG-DHA, 13-C labeled PC-DHA
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Production ofFrontiers in bioengineering and biotechnology · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Mayssa HachemUniv-Lyon, CarMeN Laboratory, Inserm UMR 1060, Inra UMR 1397, IMBL, INSA-Lyon, 69100 Villeurbanne, France.
Houda NacirUniv-Lyon, CarMeN Laboratory, Inserm UMR 1060, Inra UMR 1397, IMBL, INSA-Lyon, 69100 Villeurbanne, France.
Madeleine PicqUniv-Lyon, CarMeN Laboratory, Inserm UMR 1060, Inra UMR 1397, IMBL, INSA-Lyon, 69100 Villeurbanne, France.
Mounir BelkouchUniv-Lyon, CarMeN Laboratory, Inserm UMR 1060, Inra UMR 1397, IMBL, INSA-Lyon, 69100 Villeurbanne, France.
Nathalie Bernoud-HubacUniv-Lyon, CarMeN Laboratory, Inserm UMR 1060, Inra UMR 1397, IMBL, INSA-Lyon, 69100 Villeurbanne, France.
Anthony WindustNational Research Council Canada, Ottawa, ON K1A 0R6, Canada.
Laure MeillerUniv-Lyon, CarMeN Laboratory, Inserm UMR 1060, Inra UMR 1397, IMBL, INSA-Lyon, 69100 Villeurbanne, France.
Valerie SauvinetUniv-Lyon, CarMeN Laboratory, Inserm UMR 1060, Inra UMR 1397, IMBL, INSA-Lyon, 69100 Villeurbanne, France.
Nathalie FeugierHospices Civils de Lyon, Groupement Hospitalier Sud, 69310 Pierre-Bénite, France.
Stephanie Lambert-PorcheronHospices Civils de Lyon, Groupement Hospitalier Sud, 69310 Pierre-Bénite, France.
Martine LavilleUniv-Lyon, CarMeN Laboratory, Inserm UMR 1060, Inra UMR 1397, IMBL, INSA-Lyon, 69100 Villeurbanne, France.
Michel LagardeUniv-Lyon, CarMeN Laboratory, Inserm UMR 1060, Inra UMR 1397, IMBL, INSA-Lyon, 69100 Villeurbanne, France.
Université Claude Bernard Lyon 1 · FRHospices Civils de Lyon · FRNational Research Council Canada · CA

Funding

Agence Nationale de la Recherche Neuroprotect 2008
6 · The paper itself

Abstract

AceDoPC

Indexed as

Administration, OralAgedBiological AvailabilityCross-Over StudiesDocosahexaenoic AcidsDouble-Blind MethodErythrocytesFranceGas Chromatography-Mass SpectrometryHumansMaleMiddle AgedPhosphatidylcholinesTime FactorsTriglycerides1-acetyl-2-docosahexaenoyl-glycerophosphocholineDocosahexaenoic AcidsPhosphatidylcholinesTriglyceridesbraingas chromatography combustion isotope ratio mass spectrometryplasma phospholipids

Identifiers

PMID31963708
PMCPMC7020088
OpenAlexW2998938881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.